Immunogen (IMGN) Posts Q4 Loss of 71c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Cantor Fitzgerald Downgrades Immunogen Inc. (IMGN) to Hold
August 3, 2015 6:43 AM EDTCantor Fitzgerald downgraded Immunogen Inc. (NASDAQ: IMGN) from Buy to Hold with a price target of $21.00 (from $12.00) on valuation.
Analyst Mara Goldstein commented, "We are downgrading ImmunoGen shares to HOLD from BUY, and raising our PT to $21 from $12. Our PT raise reflects... More
Immunogen (IMGN) PT Raised to $24 at Oppenheimer Ahead of '853 Path Forward
July 29, 2015 8:33 AM EDTOppenheimer analyst Christopher Marai reiterated an Outperform rating and raised his price target on Immunogen Inc. (NASDAQ: IMGN) to $24.00 (from $13.00) in anticipation of clarity on '853's path forward and updated data by
YE15. We also anticipate these updates, potentially on Friday's... More
